GR3029740T3 - Fragments of prion proteins. - Google Patents

Fragments of prion proteins.

Info

Publication number
GR3029740T3
GR3029740T3 GR990400825T GR990400825T GR3029740T3 GR 3029740 T3 GR3029740 T3 GR 3029740T3 GR 990400825 T GR990400825 T GR 990400825T GR 990400825 T GR990400825 T GR 990400825T GR 3029740 T3 GR3029740 T3 GR 3029740T3
Authority
GR
Greece
Prior art keywords
fragments
prion proteins
polypeptides
antibodies
manufacture
Prior art date
Application number
GR990400825T
Other languages
English (en)
Inventor
Robert Vincent Bradl Fishleigh
Barry Robson
Roger Paul Mee
Original Assignee
Proteus Molecular Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26299955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3029740(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919125747A external-priority patent/GB9125747D0/en
Priority claimed from GB929214663A external-priority patent/GB9214663D0/en
Application filed by Proteus Molecular Design filed Critical Proteus Molecular Design
Publication of GR3029740T3 publication Critical patent/GR3029740T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
GR990400825T 1991-12-03 1999-03-19 Fragments of prion proteins. GR3029740T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919125747A GB9125747D0 (en) 1991-12-03 1991-12-03 Synthetic polypeptides
GB929214663A GB9214663D0 (en) 1992-07-10 1992-07-10 Synthetic polypeptides
PCT/GB1992/002246 WO1993011155A1 (en) 1991-12-03 1992-12-03 Fragments of prion proteins

Publications (1)

Publication Number Publication Date
GR3029740T3 true GR3029740T3 (en) 1999-06-30

Family

ID=26299955

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400825T GR3029740T3 (en) 1991-12-03 1999-03-19 Fragments of prion proteins.

Country Status (12)

Country Link
US (3) US5773572A (el)
EP (1) EP0616613B1 (el)
JP (1) JP4233604B2 (el)
AT (1) ATE177754T1 (el)
AU (1) AU675053B2 (el)
CA (1) CA2124953C (el)
DE (1) DE69228701T2 (el)
DK (1) DK0616613T3 (el)
ES (1) ES2128362T3 (el)
GR (1) GR3029740T3 (el)
NZ (1) NZ246059A (el)
WO (1) WO1993011155A1 (el)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618673A (en) * 1991-08-20 1997-04-08 British Technology Group Limited Oligonucleotides and their use in an assay for encephalopathies
CA2143823C (en) 1992-08-27 2005-07-26 Alfio Comis Retro-, inverso - and retro-inverso synthetic peptide analogues
DE4402756A1 (de) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US5948763A (en) * 1995-06-07 1999-09-07 New York University Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
EP1186662A3 (en) * 1996-05-29 2003-01-15 McGILL UNIVERSITY Prion binding proteins and uses thereof
GB2319607A (en) * 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
EP0909388B1 (en) * 1997-02-06 2003-09-24 Enfer Technology Limited Immunological assay for spongiform encephalopathies
US20020168689A1 (en) * 1997-02-06 2002-11-14 O'connor Michael Immunological assay for Spongiform Encephalopathies
US6593105B1 (en) 1997-02-14 2003-07-15 Deutsches Krebsforschungszentrum Stiftung Des Offentilichen Rechts Prion propagation inhibition by dominant-negative prion protein mutants
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
AU749792B2 (en) * 1997-04-01 2002-07-04 Theracos, Inc. Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
CA2291720A1 (en) * 1997-05-30 1998-12-03 Ernst-Ludwig Winnacker Pharmaceutical compositions comprising a soluble laminin receptor precursor of a compound which blocks the interaction of the laminin receptor precursor and prpsc or prpc
DE19725619A1 (de) * 1997-06-17 1998-12-24 Fraunhofer Ges Forschung Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien
DE19741607A1 (de) * 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen
US6211149B1 (en) 1998-08-03 2001-04-03 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of formation of protease resistant prion protein
US6166187A (en) * 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
EP1187920A2 (en) * 1999-06-09 2002-03-20 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
MXPA01013186A (es) * 1999-06-23 2002-08-12 Caprion Pharmaceuticals Inc Peptidos de la proteina prion y sus usos.
US6872806B1 (en) * 1999-06-25 2005-03-29 The Governors Of The University Of Alberta Polypeptide compositions formed using a coiled-coil template and methods of use
US6261790B1 (en) * 1999-07-15 2001-07-17 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
US6437102B1 (en) 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
AU2001251358A1 (en) * 2000-04-05 2001-10-23 V.I. Technologies, Inc. Prion-binding ligands and methods of using same
US7098317B1 (en) * 2000-05-23 2006-08-29 Blood Transfusion Center Of Slovenia Antibodies capable to selectively detect prion PrPSc isoforms
ATE312848T1 (de) * 2000-05-23 2005-12-15 Blood Transfusion Ct Of Sloven Antikörper zum selektiven nachweis von prion prp sc isoformen
WO2001097785A2 (en) * 2000-06-20 2001-12-27 Caprion Pharmaceuticals Inc. Basic copolymers for the treatment of prion-related-disease
WO2002046236A1 (fr) * 2000-12-08 2002-06-13 Fujirebio Inc. Anticorps monoclonal dirigé contre un prion anormal, procédé de production correspondant, et procédé d'essai immunologique l'utilisant
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
US6613505B2 (en) 2001-04-12 2003-09-02 Bioresource International, Inc. Composition and method for destruction of infetious prion proteins
US7166471B2 (en) * 2001-05-31 2007-01-23 Arete Associates Misfolded protein sensor method in body fluids
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
CA2481437A1 (en) * 2002-04-09 2003-10-16 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
US20060057636A1 (en) * 2002-08-21 2006-03-16 Peter Heegaard Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
ES2460641T3 (es) * 2002-12-03 2014-05-14 Pathogen Removal And Diagnostic Technologies, Inc. Ligandos de proteínas priones y procedimientos de uso
US6979672B2 (en) * 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
EP1449536A1 (en) * 2003-02-14 2004-08-25 Prionics AG Prion proteins (PrP) as therapeutic agents for the treatment of AP-1 associated diseases
US20040192887A1 (en) * 2003-03-25 2004-09-30 Ralph Zahn PH-dependent polypeptide aggregation and its use
EP1615992B1 (en) 2003-04-04 2013-08-28 Pathogen Removal and Diagnostic Technologies, Inc. Prion protein binding materials and methods of use
US7510848B2 (en) * 2003-04-04 2009-03-31 North Carolina State University Prion protein binding materials and methods of use
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
EP1653844B1 (en) 2003-08-13 2012-12-12 Novartis Vaccines and Diagnostics, Inc. Prion-specific peptide reagents
RU2267496C2 (ru) * 2004-01-15 2006-01-10 Сергей Иванович Черныш Противоопухолевые и антивирусные пептиды
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
GB0402123D0 (en) * 2004-01-30 2004-03-03 Protherics Plc Method
GB0416699D0 (en) 2004-07-27 2004-09-01 Prometic Biosciences Ltd Prion protein ligands and methods of use
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
NZ560535A (en) * 2005-01-13 2011-01-28 Novartis Vaccines & Diagnostic Elisa assays using prion-specific peptide reagents
MX2007009819A (es) * 2005-02-15 2007-11-07 Adlyfe Inc Metodo para detectar proteinas y priones desplegados.
JP5614930B2 (ja) 2005-06-10 2014-10-29 プロメティック バイオサイエンシズ，リミテッド タンパク質結合性リガンドとしてのトリアジン
CA2621767A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
US20070196863A1 (en) * 2006-02-17 2007-08-23 Hanson Technologies, Inc. Prion protein detection
EP2156181B1 (en) * 2006-07-28 2015-11-04 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
EP2282753A1 (en) * 2008-04-30 2011-02-16 Novartis AG Assay for pathogenic conformers
EP2135880A1 (en) 2008-06-17 2009-12-23 Heinrich-Heine-Universität Düsseldorf Anti-prion protein antibody fragment
EP2342220B1 (en) 2008-10-06 2021-05-12 The University Of British Columbia Methods and systems for predicting misfolded protein epitopes
US9492472B2 (en) * 2008-12-23 2016-11-15 Case Western Reserve University Compositions and methods of treating cancer
CA2753621A1 (en) * 2009-03-02 2010-09-10 The University Of British Columbia Antibodies and epitopes specific to misfolded prion protein
WO2013166183A2 (en) * 2012-05-02 2013-11-07 Samuel Bogoch Replikin sequences and their antibodies for diagnostics, therapeutics, and vaccines against prion and neurodegenerative disorders including alzheimer's disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof

Also Published As

Publication number Publication date
DK0616613T3 (da) 1999-09-27
WO1993011155A1 (en) 1993-06-10
EP0616613B1 (en) 1999-03-17
NZ246059A (en) 1995-08-28
ATE177754T1 (de) 1999-04-15
US20030199013A1 (en) 2003-10-23
DE69228701D1 (de) 1999-04-22
ES2128362T3 (es) 1999-05-16
AU3089292A (en) 1993-06-28
CA2124953A1 (en) 1993-06-10
US6379905B1 (en) 2002-04-30
EP0616613A1 (en) 1994-09-28
US5773572A (en) 1998-06-30
JPH07501798A (ja) 1995-02-23
DE69228701T2 (de) 1999-07-29
AU675053B2 (en) 1997-01-23
CA2124953C (en) 2008-02-05
US7777011B2 (en) 2010-08-17
JP4233604B2 (ja) 2009-03-04

Similar Documents

Publication Publication Date Title
GR3029740T3 (en) Fragments of prion proteins.
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
GR3018773T3 (en) Antibodies to human papillomavirus latent proteins, diagnostic systems and methods.
AU4230493A (en) Diphtheria toxin receptor-binding region
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
DE240975T1 (de) Menschliches gamma-interferon-spezifisches rezeptorprotein, antikoerper gegen dieses protein, verfahren zur herstellung dieses proteins und dieses antikoerpers und dieses protein und diesen antikoerper enthaltende zusammensetzungen.
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
ATA111789A (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
WO1995024481A3 (en) Humanized monoclonal antibodies against human interleukin-4
WO1997045746A3 (en) Prion protein binding proteins and uses thereof
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
DE3887053T4 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
GR3007000T3 (el)
ES2103017T3 (es) Sueros estandares y de control para empleo en ensayos para anticuerpos.
DE69229948T2 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN
DE69518927T2 (de) Ein mit katp-kanälen wechselwirkendes protein
EP0334076A3 (en) Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same
AU5449390A (en) Monoclonal antibody against c-reactive protein
AU6964891A (en) Novel monoclonal antibody against human platelets
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.